Olema Pharmaceuticals, Inc. (OLMA)
35.83
+2.78
(+8.41%)
USD |
NASDAQ |
Dec 15, 16:00
35.84
+0.01
(+0.03%)
After-Hours: 20:00
Olema Pharmaceuticals Cash from Investing (Quarterly): 17.27M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Replimune Group, Inc. | 84.17M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Insmed, Inc. | -762.23M |
| Altimmune, Inc. | -149.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.53M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow | -134.67M |
| Free Cash Flow Per Share (Quarterly) | -0.4027 |
| Free Cash Flow to Equity (Quarterly) | -34.25M |
| Free Cash Flow to Firm (Quarterly) | -34.53M |
| Free Cash Flow Yield | -4.54% |